|
WO2004060403A2
(en)
|
2003-01-06 |
2004-07-22 |
Angiochem Inc. |
Aprotinin and anglos as carriers across the blood-brain barrier
|
|
ES2744225T3
(es)
|
2005-07-15 |
2020-02-24 |
Angiochem Inc |
Uso de polipéptidos de aprotinina como portadores en conjugados farmacéuticos
|
|
JP2010506860A
(ja)
|
2006-10-19 |
2010-03-04 |
アンジオケム，インコーポレーテッド |
Ｐ−糖タンパク質機能を刺激するための化合物およびその使用
|
|
US9365634B2
(en)
|
2007-05-29 |
2016-06-14 |
Angiochem Inc. |
Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
|
|
ES2798257T3
(es)
|
2008-09-08 |
2020-12-10 |
Childrens Medical Center |
Administración mucosa de moléculas, proteínas o partículas terapéuticas acopladas a lípidos de ceramida
|
|
EP2342340A1
(en)
|
2008-09-22 |
2011-07-13 |
Rxi Pharmaceuticals Corporation |
Rna interference in skin indications
|
|
CA2740316A1
(en)
|
2008-10-15 |
2010-04-22 |
Angiochem Inc. |
Conjugates of glp-1 agonists and uses thereof
|
|
CN102272151B
(zh)
|
2008-11-04 |
2014-08-20 |
詹森药业有限公司 |
Crhr2肽激动剂及其用途
|
|
CA2745524C
(en)
|
2008-12-05 |
2020-06-09 |
Angiochem Inc. |
Conjugates of neurotensin or neurotensin analogs and uses thereof
|
|
US8853353B2
(en)
|
2008-12-17 |
2014-10-07 |
Angiochem, Inc. |
Membrane type-1 matrix metalloprotein inhibitors and uses thereof
|
|
MX2011011023A
(es)
|
2009-04-20 |
2012-01-20 |
Angiochem Inc |
Tratamiento de cancer de ovarios usando un agente anti-cancer conjugado con un analogo de angiopep-2.
|
|
RU2012103240A
(ru)
|
2009-07-02 |
2013-08-10 |
Ангиокем Инк. |
Мультимерные пептидные конъюгаты и их применение
|
|
EP3560503B1
(en)
|
2010-03-24 |
2021-11-17 |
Phio Pharmaceuticals Corp. |
Rna interference in dermal and fibrotic indications
|
|
CN104145015A
(zh)
*
|
2011-12-01 |
2014-11-12 |
安吉奥开米公司 |
靶向的溶酶体酶化合物
|
|
BR112014013250A2
(pt)
*
|
2011-12-01 |
2019-09-24 |
Angiochem Inc |
compostos com enzima alvo e usos dos mesmos
|
|
US20140377244A1
(en)
*
|
2011-12-23 |
2014-12-25 |
Shire Human Genetic Therapies, Inc. |
Stable formulations for cns delivery of arylsulfatase a
|
|
WO2013127004A1
(en)
|
2012-03-02 |
2013-09-06 |
The Governing Council Of The University Of Toronto |
Polymeric nanoparticles useful in theranostics
|
|
MX2014011836A
(es)
*
|
2012-03-30 |
2015-03-09 |
Shire Human Genetic Therapies |
Administracion subcutanea de iduronato-2-sulfatasa.
|
|
AU2013273894A1
(en)
*
|
2012-06-15 |
2015-02-05 |
Angiochem Inc. |
Targeted iduronidase compounds
|
|
JP2015526434A
(ja)
*
|
2012-08-14 |
2015-09-10 |
アンジオケム インコーポレーテッド |
ペプチド−デンドリマーコンジュゲート及びその使用
|
|
WO2014031883A1
(en)
*
|
2012-08-23 |
2014-02-27 |
Susan Marie Metcalfe |
Neurotherapeutic nanoparticle compositions and devices
|
|
US20150241456A1
(en)
*
|
2012-09-20 |
2015-08-27 |
Manas K. Haldar |
Methods for using lipid particles
|
|
US9730679B1
(en)
*
|
2012-12-21 |
2017-08-15 |
University Of South Florida |
Device for sterile uterine sampling and drug delivery
|
|
KR20150098675A
(ko)
*
|
2012-12-24 |
2015-08-28 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
넌센스 돌연변이로부터 생긴 유전적 질환을 치료하기 위한 물질 및 이를 확인하는 방법
|
|
CA2902433A1
(en)
*
|
2013-03-01 |
2014-09-04 |
Astex Pharmaceuticals, Inc. |
Drug combinations
|
|
AU2014228231B2
(en)
*
|
2013-03-15 |
2019-02-21 |
Amicus Therapeutics, Inc. |
Chemical crosslinkers
|
|
WO2014191502A1
(en)
|
2013-05-28 |
2014-12-04 |
Sinvent As |
Process for preparing stealth nanoparticles
|
|
WO2014194429A1
(en)
*
|
2013-06-06 |
2014-12-11 |
Angiochem Inc. |
Targeted enzyme compounds and uses thereof
|
|
US9198973B2
(en)
*
|
2013-06-17 |
2015-12-01 |
Fundacion Fraunhofer Chile Research |
PAMAM, spacer molecule and cafestol polymers
|
|
PL3027750T3
(pl)
*
|
2013-07-30 |
2019-09-30 |
Inofea Ag |
Kompozycja biokatalityczna
|
|
CN103405783B
(zh)
*
|
2013-08-05 |
2015-08-12 |
中山大学孙逸仙纪念医院 |
OX26/CTX-PL/pC27复合物及其在治疗神经胶质瘤中的应用
|
|
US20150093399A1
(en)
|
2013-08-28 |
2015-04-02 |
Bioasis Technologies, Inc. |
Cns-targeted conjugates having modified fc regions and methods of use thereof
|
|
IN2013MU03918A
(https=)
*
|
2013-12-13 |
2015-09-25 |
Cipla Ltd |
|
|
NZ720499A
(en)
*
|
2013-12-23 |
2020-04-24 |
Bcn Peptides Sa |
Bicalutamide analogs or (s)-bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal storage disorder or glycogenosis
|
|
ES2981281T3
(es)
|
2014-01-20 |
2024-10-08 |
Univ Utah Res Found |
Composiciones y métodos para modificar la superficie de las células y métodos de uso
|
|
US20180133331A1
(en)
*
|
2014-02-05 |
2018-05-17 |
William Henry Gmeiner |
Site-Specific DNA-Doxorubicin Conjugates Display Enhanced Cytotoxicity to Breast Cancer Cells
|
|
WO2015168108A2
(en)
|
2014-04-28 |
2015-11-05 |
Rxi Pharmaceuticals Corporation |
Methods for treating cancer using nucleic targeting mdm2 or mycn
|
|
CN105585614B
(zh)
*
|
2014-10-24 |
2019-06-07 |
中国科学技术大学 |
用于淀粉样蛋白显像的血管肽及其衍生物
|
|
EP3225255B1
(en)
*
|
2014-11-28 |
2020-08-19 |
Cysay Inc. |
Carbosilane dendrimer and aggregatable carrier obtained using said dendrimer for drug delivery system
|
|
GB201508025D0
(en)
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Fabry disease gene therapy
|
|
EP3307326B9
(en)
|
2015-06-15 |
2021-02-24 |
Angiochem Inc. |
Methods for the treatment of leptomeningeal carcinomatosis
|
|
WO2017004518A1
(en)
*
|
2015-07-02 |
2017-01-05 |
The Regents Of The University Of California |
Site-targeted nano-liposomal nitroglycerin therapeutics
|
|
US10808247B2
(en)
*
|
2015-07-06 |
2020-10-20 |
Phio Pharmaceuticals Corp. |
Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach
|
|
WO2017005734A1
(en)
|
2015-07-06 |
2017-01-12 |
Ucb Biopharma Sprl |
Tau-binding antibodies
|
|
WO2017094792A1
(ja)
*
|
2015-11-30 |
2017-06-08 |
株式会社Ｑｕａｒｒｙｍｅｎ＆Ｃｏ． |
カルボシランデンドリマーを用いた薬物送達システム用標的型シェル
|
|
CN109620949A
(zh)
*
|
2016-03-13 |
2019-04-16 |
曹帅 |
一种用于治疗骨癌的药物组合物
|
|
AU2017378427A1
(en)
*
|
2016-12-14 |
2019-06-20 |
Ligandal, Inc. |
Methods and compositions for nucleic acid and protein payload delivery
|
|
CN106692080A
(zh)
*
|
2016-12-29 |
2017-05-24 |
合肥安德生制药有限公司 |
一种制备注射用紫杉肽的冻干工艺
|
|
EP3700549A4
(en)
|
2017-10-27 |
2021-08-18 |
Children's Medical Center Corporation |
LIPIDS BASED ON SHORT CHAIN CERAMIDES AND THEIR USES
|
|
CN111465611B
(zh)
*
|
2017-12-01 |
2024-10-11 |
古德T细胞有限公司 |
预防或治疗脱发的组合物
|
|
SG11202006142PA
(en)
|
2018-01-12 |
2020-07-29 |
Roche Innovation Ct Copenhagen As |
Alpha-synuclein antisense oligonucleotides and uses thereof
|
|
AU2019252912A1
(en)
|
2018-04-12 |
2020-10-22 |
The Children's Medical Center Corporation |
Ceramide-like lipid-based delivery vehicles and uses thereof
|
|
US20210206805A1
(en)
*
|
2018-05-23 |
2021-07-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Cardiac-specific targeting-peptide (ctp), compositions, and uses thereof
|
|
RU2727924C1
(ru)
*
|
2019-08-20 |
2020-07-27 |
Открытое акционерное общество "Всероссийский научный центр молекулярной диагностики и лечения" (ОАО "ВНЦМДЛ") |
Высокоэффективный способ получения лекарственной формы адресного действия для терапии злокачественных новообразований
|
|
MX2022003570A
(es)
*
|
2019-09-25 |
2022-07-11 |
Codiak Biosciences Inc |
Composiciones de vesícula extracelular.
|
|
CA3128035A1
(en)
|
2020-08-13 |
2022-02-13 |
Bioasis Technologies, Inc. |
Combination therapies for delivery across the blood brain barrier
|
|
EP4213810A4
(en)
*
|
2020-09-16 |
2025-06-18 |
Imagion Biosystems, Inc. |
Methods and apparatuses for the synthesis of drug-loaded magnetic micelle aggregates
|
|
WO2022173827A1
(en)
*
|
2021-02-09 |
2022-08-18 |
Phoenix Nest Inc. |
Nootropic peptides for treating lysosomal storage diseases
|
|
US20220378940A1
(en)
*
|
2021-05-27 |
2022-12-01 |
Northwestern University |
Phase-segregated vesicles for spatially controlled protein-conjugation and cell therapy
|